Abstract
Redo surgery is regarded as the first-line treatment option for patients presenting with prosthetic valve degeneration. However, many patients have concomitant co-morbidities and this option is associated with significant risk. Transcatheter valve-in-valve implantation is an alternative strategy depending on the bioprosthetic valve that is being treated. The Sorin Mitroflow bioprosthetic aortic valve has been regarded as a contraindication to valve-in-valve treatment due to the high risk of coronary obstruction. We here present the case of a patient with small peripheral vasculature who underwent successful transfemoral valve-in-valve implantation and subsequently discuss the challenges and technical aspects that require consideration.
Original language | English (US) |
---|---|
Pages (from-to) | 292-295 |
Number of pages | 4 |
Journal | Cardiovascular Intervention and Therapeutics |
Volume | 31 |
Issue number | 4 |
DOIs | |
State | Published - Oct 1 2016 |
Externally published | Yes |
Keywords
- Coronary obstruction
- Evolut R
- Mitroflow
- Transcatheter aortic valve implantation
- Valve-in-valve
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cardiology and Cardiovascular Medicine